SCHEMBL30733965

SCHEMBL30733965

O=C(c1cccc(Br)c1)c1cccc2cccn12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.46
ALDH1A1 P00352 4/20 0.45
TP53 P04637 1/20 0.45
HPGD P15428 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
HTT P42858 1/20 0.39
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL3 Q96JM7 2/20 0.39
L3MBTL4 Q8NA19 1/20 0.39
FNTA P49354 1/20 0.39
FNTB P49356 1/20 0.39
C1S P09871 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30733925 0.81 POLB (0.57) PARP1ALDH1A1MEN1KMT2AHTT
SCHEMBL30733922 0.81 POLB (0.46) PARP1HPGDMAPTMEN1KMT2A
SCHEMBL30733928 0.81 PARP1 (0.46) PARP1ALDH1A1L3MBTL1MAPTMEN1
SCHEMBL15201237 0.79 PARP1 (0.47) PARP1ALDH1A1TP53HPGDL3MBTL1
SCHEMBL27004449 0.78 KDM4E (0.43) ALDH1A1TP53L3MBTL1MAPTGAA
SCHEMBL29822455 0.78 KDM4E (0.43) ALDH1A1TP53L3MBTL1MAPTGAA
SCHEMBL27001662 0.78 FFAR1 (0.44) PARP1ALDH1A1TP53L3MBTL1KMT2A
SCHEMBL241785 0.75 PARP1 (0.68) PARP1ALDH1A1TP53HPGDL3MBTL1
SCHEMBL30153175 0.75 PARP1 (0.68) PARP1ALDH1A1TP53HPGDL3MBTL1
SCHEMBL30733931 0.74 MEN1 (0.41) ALDH1A1TP53HPGDMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228487-A1 FUSED HETEROCYCLIC COMPOUND AND APPLICATION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND APPLICATION THEREOF ZHEJIANG UNIVERSITY (CN) 2024-07-11 US disclosed
EP-4306522-A1 FUSED RING HETEROCYCLIC COMPOUND AND APPLICATION THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AND APPLICATION THEREOF Zhejiang University (CN) 2024-01-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228487-A1 FUSED HETEROCYCLIC COMPOUND AND APPLICATION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND APPLICATION THEREOF TRPM2, TRPM8, TRPM7 PARP1 4355/4885ALDH1A1 2555/4885TP53 2587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.